Articles On Pharmaxis (ASX:PXS)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Pharmaxis continues to add value to portfolio assets; Bronchitol reaches pivotal stage
The company is confident that the FDA will have the information it requires to be able to approve Bronchitol by Q1 2020. |
Proactive Investors | PXS | 5 years ago |
|
Dr Boreham’s Crucible: Pharmaxis shareholders breathe easy – the FDA loves you
Pharmaxis (ASX:PXS) chief Gary Phillips is keen to differentiate the drug developer from his local peers, noting the company has several potential paths to glory rather than a singular approach. “A lot of biotechs in Australia are a one-pro... |
Stockhead | PXS | 5 years ago |
|
Is the Starpharma share price a buy?
I have recently spent some time reviewing the annual reports and announcements from S&P/ASX 200 (INDEXASX: XJO) index-listed company, Starpharma Holdings Limited (ASX: SPL) to assess the merit of buying SPL shares. Starpharma shares la... |
Motley Fool | PXS | 5 years ago |
|
Rudi’s View: Amcor, Banks, Winners & Losers In Gold
In this week's Weekly Insights (published in two parts):-Crucial Question: Is It 1995 or 2007?-Conviction Calls -Gold Stocks: Winners & Losers-Rudi On Tour -Rudi TalksConviction Calls By Rudi Filapek-Vandyck, Editor FNArena Stockb... |
FNArena | PXS | 5 years ago |
|
5 Stocks From A Leading Stockbroker’s FY20 Picks
Avita Medical Ltd Strong Performance During the Third Quarter of 2019: Avita Medical Ltd (ASX: AVH) released its quarterly report for the period ended 31 March 2019 on 30 April 2019. The company mentioned that for the third quarter of 2019,... |
Kalkine Media | PXS | 5 years ago |
|
Pharmaxis on track to complete FDA approval process for Bronchitol in Q1 2020
If Bronchitol is approved by the US FDA, Pharmaxis will receive US$10 million. |
Proactive Investors | PXS | 5 years ago |